Walmart has become the latest big pharmacy chain in the US to put forward a settlement to resolve claims it contributed to the national opioid crisis by failing to regulate prescriptions at its outlets. The retail giant has confirmed it…
FDA grants IND clearance for NeuroSense’s Phase IIb ALS trial
The trial is designed to evaluate the efficacy, safety, and tolerability of PrimeC in ALS patients. The US Food and Drug Administration (FDA) has granted clearance for NeuroSense Therapeutics’ Investigational New Drug (IND) application to enrol patients in the country in its…
Experimental breast cancer vaccine proves safe in phase 1 clinical trials
Breast cancer is currently the most frequently diagnosed cancerTrusted Source in the United States, and globally it is the world’s most prevalent cancer. According to new phase 1 clinical trial data, a new plasmid DNA-based vaccine that is able to…
OneStudyTeam and Antidote partner to boost recruitment in trials
StudyTeam follows trial subjects through to enrolment and offers visibility to sponsors at each step of the enrolment process. OneStudyTeam has signed a collaboration with Antidote Technologies to offer an integrated, end-to-end patient referral management approach to sites and sponsors…
OnQuality enrols first subject in Phase II HFSR therapy trial
The key objectives include the assessment of the efficacy and safety of OQL011 and the identification of an optimal dosage for Phase III. Targeted oncology supportive therapy company OnQuality Pharmaceuticals has enrolled the first participant in Part 2 of the…
Lilly preps for rollout of its connected diabetes system
After years of preparation, Eli Lilly is on the brink of launching a fully connected and personalised diabetes management platform, underpinned by digital technologies. The Tempo system brings together a pre-filled insulin pen, the TempoSmart app and a recently-approved Smart…
Respiri recruits first patients in US wheezo programme
Australian digital health company Respiri has started to roll out its digital remote patient monitoring (RPM) system for asthma and chronic obstructive pulmonary disease (COPD) in the US, with the first patients now signed up to the programme. The Software…
Sanofi signs $1.2bn research alliance with AI specialist Insilico
Sanofi has tapped into the artificial intelligence expertise of Chinese biotech Insilico Medicine with a six-compound drug discovery collaboration that could be worth up to $1.2 billion. The alliance is backloaded, with $21.5 million paid upfront and Insilico also in…
People Receive Lab‑Grown Blood in World‑First Clinical Trial
In a first-of-its-kind clinical trial, blood grown in the laboratory has been transfused into people. If this technology is proven effective, lab-grown blood could potentially revolutionize treatment for people with blood disorders and rare blood types. Researchers say this trial…
